Skip to content

Determination of a Hyperoxia/Hypoxia Cut-off During Stopflow in Regional Chemotherapy

Determination of a Hyperoxia/Hypoxia Cut-off During Stopflow in Regional Chemotherapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00034857
Enrollment
100
Registered
2024-10-04
Start date
2025-07-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OPS 8-843.0: "Regional Chemotherapy (e.g., Intra-arterial Chemotherapy)" OPS 8-845.0: "Isolated Organ Perfusion with Chemotherapy"

Interventions

Group 1: During the period of stopflow in regional chemotherapy, arterial and venous blood gas samples (BGA) are taken and evaluated every 2 minutes through catheters placed in the aorta and the vena

Sponsors

Medias-Klinikum Burghausen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Regional Chemotherapy with Stop-Flow

Exclusion criteria

Exclusion criteria: no StopFlow

Design outcomes

Primary

MeasureTime frame
The precise determination of the hypoxia cut-off point regarding arterial and venous oxygen saturation in relation to time and BMI during the stopflow phase.

Secondary

MeasureTime frame
Recording of region-specific arterial and venous pressures during the stopflow

Countries

Germany

Contacts

Public ContactHansjörg Aust

Medias-Klinikum Burghausen

h.aust@medias-klinikum.de+49 (0) 86 77/91 60- 4

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026